Inflammatory linear verrucous epidermal nevus: a rare experience

Authors

  • Haresh Kumar

DOI:

https://doi.org/10.66344/jpad.32.1.2022.1801

Abstract

Inflammatory linear verrucous epidermal nevus is an uncommon variant of epidermal nevus, caused by unknown postzygotic mutation rescued by genetic mosaicism. Clinically, it presents as intensely pruritic, erythematous, psoriasiform and verrucous, papules and plaques following the lines of Blaschko, mostly involving the single leg. It has usually early life onset. However, since its first description, very few cases have been reported which were of adult onset. Herein, we report a case of ILVEN in a 22‑year‑old male.

Author Biography

Haresh Kumar

Abstract Inflammatory linear verrucous epidermal nevus is an uncommon variant of epidermal nevus, caused by unknown postzygotic mutation rescued by genetic mosaicism. Clinically, it presents as intensely pruritic, erythematous, psoriasiform and verrucous, papules and plaques following the lines of Blaschko, mostly involving the single leg. It has usually early life onset. However, since its first description, very few cases have been reported which were of adult onset. Herein, we report a case of ILVEN in a 22 year old male.

Downloads

Published

2022-03-29

How to Cite

1.
Haresh Kumar. Inflammatory linear verrucous epidermal nevus: a rare experience. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026Apr.12];32(1):191-4. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1801

Issue

Vol. 32 No. 1 (2022): January - March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.